| Product Code: ETC8939751 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Republic of North Macedonia saw a significant increase in therapeutic vaccines import shipments in 2024, with top exporting countries being the UK, USA, China, Sweden, and Japan. Despite high concentration levels indicated by the HHI, the market continued to grow steadily with a CAGR of 9.15% from 2020 to 2024. The growth rate in 2024 surged to 10.69%, reflecting a strong demand for therapeutic vaccines in the region. This trend highlights the country`s reliance on these key exporting nations for meeting its healthcare needs and signifies a promising market outlook for the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Republic of Macedonia Therapeutic Vaccines Market Overview |
3.1 Republic of Macedonia Country Macro Economic Indicators |
3.2 Republic of Macedonia Therapeutic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Republic of Macedonia Therapeutic Vaccines Market - Industry Life Cycle |
3.4 Republic of Macedonia Therapeutic Vaccines Market - Porter's Five Forces |
3.5 Republic of Macedonia Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Republic of Macedonia Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2021 & 2031F |
4 Republic of Macedonia Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Republic of Macedonia Therapeutic Vaccines Market Trends |
6 Republic of Macedonia Therapeutic Vaccines Market, By Types |
6.1 Republic of Macedonia Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Republic of Macedonia Therapeutic Vaccines Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Republic of Macedonia Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2021- 2031F |
6.1.4 Republic of Macedonia Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2021- 2031F |
6.1.5 Republic of Macedonia Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2021- 2031F |
6.2 Republic of Macedonia Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 Republic of Macedonia Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2021- 2031F |
6.2.3 Republic of Macedonia Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2021- 2031F |
6.2.4 Republic of Macedonia Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2021- 2031F |
6.2.5 Republic of Macedonia Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2021- 2031F |
6.2.6 Republic of Macedonia Therapeutic Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 Republic of Macedonia Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 Republic of Macedonia Therapeutic Vaccines Market Export to Major Countries |
7.2 Republic of Macedonia Therapeutic Vaccines Market Imports from Major Countries |
8 Republic of Macedonia Therapeutic Vaccines Market Key Performance Indicators |
9 Republic of Macedonia Therapeutic Vaccines Market - Opportunity Assessment |
9.1 Republic of Macedonia Therapeutic Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Republic of Macedonia Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2021 & 2031F |
10 Republic of Macedonia Therapeutic Vaccines Market - Competitive Landscape |
10.1 Republic of Macedonia Therapeutic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Republic of Macedonia Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |